{"title":"Arbeitsunfähigkeit – Schritt-für-Schritt","authors":"J. Herbers","doi":"10.1055/a-1762-2010","DOIUrl":"https://doi.org/10.1055/a-1762-2010","url":null,"abstract":"In jeder Arztpraxis werden täglich Patienten „krankgeschrieben“. Was aber so intuitiv daherkommt, ist ein formaljuristischer Prozess, dem viele Regelungen zugrunde liegen. Und wie so oft, kommt es in manchen Fällen darauf an, diese Regelungen auch genauer zu kennen. Ein falsches Kreuz oder eine nicht mehr aktuelle ICD-10-Ziffer auf dem AU-Formular können noch nach Jahren erhebliche Auswirkungen haben.","PeriodicalId":303699,"journal":{"name":"Allgemeinmedizin up2date","volume":"144 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121293644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Verordnung von Nirmatrelvir/Ritonavir (Paxlovid): Logistik und Indikation in der hausärztlichen Praxis","authors":"M. Magistro","doi":"10.1055/a-1948-8183","DOIUrl":"https://doi.org/10.1055/a-1948-8183","url":null,"abstract":"Paxlovid ist ein antivirales Arzneimittel zur oralen Anwendung in der Behandlung von COVID-19 Frühinfektionen. Es besteht aus 2 Wirkstoffen: Nirmatrelvir, welches die SARS-CoV-2-Hauptprotease inhibiert und so die Virusreplikation verhindert, und Ritonavir, welches den CYP3A-vermittelten Metabolismus von Nirmatrelvir hemmt und so für eine höhere Plasmakonzentration des Proteaseinhibitors sorgt.","PeriodicalId":303699,"journal":{"name":"Allgemeinmedizin up2date","volume":"35 11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124373697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hautausschläge bei Kindern und Jugendlichen","authors":"Lisa Degener","doi":"10.1055/a-1398-4333","DOIUrl":"https://doi.org/10.1055/a-1398-4333","url":null,"abstract":"","PeriodicalId":303699,"journal":{"name":"Allgemeinmedizin up2date","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132569643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Typ-2-Diabetes: kardiovaskuläre Ergebnisse von SGLT-2-Inhibitoren und Metformin","authors":"","doi":"10.1055/a-1783-2417","DOIUrl":"https://doi.org/10.1055/a-1783-2417","url":null,"abstract":"","PeriodicalId":303699,"journal":{"name":"Allgemeinmedizin up2date","volume":"238 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122654615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}